An Observational Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

Trial Profile

An Observational Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2018

At a glance

  • Drugs Atezolizumab (Primary)
  • Indications Urogenital cancer
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 09 Feb 2018 Planned initiation date changed from 12 Dec 2017 to 28 Feb 2018.
    • 01 Dec 2017 Planned initiation date changed from 20 Nov 2017 to 12 Dec 2017.
    • 08 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top